Trials / Completed
CompletedNCT01903213
Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 123 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bixalomer | Oral |
Timeline
- Start date
- 2013-03-19
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2013-07-19
- Last updated
- 2024-10-22
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01903213. Inclusion in this directory is not an endorsement.